Concepedia

Martha Wadleigh

MW

109

Publications

16.5K

Citations

53

H-Index

1997

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

Brigham and Women's Hospital

The University of Texas MD Anderson Cancer Center

Martha Wadleigh is an author at Dana-Farber Cancer Institute specializing in medicine, hematology, and pathology.

ORCID

Top concepts

Publications per year

1997–2024

109

Publications

109

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools et al. · Cancer Cell · 2005 · 3K citations · Full text

, , +11

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

Yana Pikman, Benjamin H. Lee, Thomas Mercher et al. · PLoS Medicine · 2006 · 1.4K citations · Full text

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

Animesh Pardanani, Ross L. Levine, Terra L. Lasho et al. · Blood · 2006 · 1K citations · Full text

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola et al. · Blood · 2014 · 960 citations · Full text

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

Omar Abdel‐Wahab, Ann Mullally, Cyrus V. Hedvat et al. · Blood · 2009 · 713 citations · Full text

Rows per page

1–5 of 109